The tail of integrin activation

Trends in Biochemical Sciences

Volumn 36, Issue 4, 2011, Pages 191-198

  Anthis, Nicholas J ^a   Campbell, Iain D ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; TALIN;

CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; IMMUNE RESPONSE; METAZOON; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR;

ANIMALS; HUMANS; INTEGRINS; MODELS, MOLECULAR; PHOSPHORYLATION; PROTEIN BINDING; TALIN;

METAZOA;

EID: 79954414698     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2010.11.002     Document Type: Review

References (85)

1. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
2. Barczyk M., et al. Integrins. Cell Tissue Res. 2010, 339:269-280.
3. Humphries J.D., et al. Integrin ligands at a glance. J. Cell Sci. 2006, 119:3901-3903.
4. Luo B.H., et al. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 2007, 25:619-647.
5. Harburger D.S., Calderwood D.A. Integrin signalling at a glance. J. Cell Sci. 2009, 122:159-163.
6. Baker E.L., Zaman M.H. The biomechanical integrin. J. Biomech. 2010, 43:38-44.
7. Schwartz M.A., Ginsberg M.H. Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 2002, 4:E65-68.
8. Huveneers S., Danen E.H. Adhesion signaling - crosstalk between integrins, Src and Rho. J. Cell Sci. 2009, 122:1059-1069.
9. Ye F., et al. Recreation of the terminal events in physiological integrin activation. J. Cell Biol. 2010, 188:157-173.
10. Legate K.R., et al. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev. 2009, 23:397-418.
11. Critchley D.R. Biochemical and structural properties of the integrin-associated cytoskeletal protein talin. Annu. Rev. Biophys. 2009, 38:235-254.
12. Alon R., Dustin M.L. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity 2007, 26:17-27.
13. Zhu J., et al. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol. Cell 2008, 32:849-861.
14. Wolfenson H., et al. The heel and toe of the cell's foot: a multifaceted approach for understanding the structure and dynamics of focal adhesions. Cell Motil. Cytoskeleton 2009, 66:1017-1029.
15. Zaidel-Bar R., et al. Functional atlas of the integrin adhesome. Nat. Cell Biol. 2007, 9:858-867.
16. Humphries J.D., et al. Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6. Sci. Signal. 2009, 2:ra51.
17. Tompa P., et al. Close encounters of the third kind: disordered domains and the interactions of proteins. Bioessays 2009, 31:328-335.
18. Legate K.R., Fassler R. Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails. J. Cell Sci. 2009, 122:187-198.
19. Deakin N.O., et al. An integrin-α4-14-3-3ζ-paxillin ternary complex mediates localised Cdc42 activity and accelerates cell migration. J. Cell Sci. 2009, 122:1654-1664.
20. Wegener K.L., Campbell I.D. Transmembrane and cytoplasmic domains in integrin activation and protein-protein interactions (review). Mol. Membr. Biol. 2008, 25:376-387.
21. Nieves B., et al. The NPIY motif in the integrin beta1 tail dictates the requirement for talin-1 in outside-in signaling. J. Cell Sci. 2010, 123:1216-1226.
22. Shattil S.J., Ginsberg M.H. Integrin signaling in vascular biology. J. Clin. Invest. 1997, 100:S91-95.
23. Evans R., et al. Integrins in immunity. J. Cell Sci. 2009, 122:215-225.
24. Shattil S.J., et al. The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell Biol. 2010, 11:288-300.
25. Baker R.G., Koretzky G.A. Regulation of T cell integrin function by adapter proteins. Immunol. Res. 2008, 42:132-144.
26. Lee H.S., et al. RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J. Biol. Chem. 2009, 284:5119-5127.
27. de Pereda J.M., et al. Structural basis for phosphatidylinositol phosphate kinase type Iγ binding to talin at focal adhesions. J. Biol. Chem. 2005, 280:8381-8386.
28. Wernimont S.A., et al. PIPKI gamma 90 negatively regulates LFA-1-mediated adhesion and activation in antigen-induced CD4+ T cells. J. Immunol. 2010, 185:4714-4723.
29. Wernimont S.A., et al. Calpain 4 is not necessary for LFA-1-mediated function in CD4+ T cells. PLoS One 2010, 5:e10513.
30. Franco S.J., Huttenlocher A. Regulating cell migration: calpains make the cut. J. Cell Sci. 2005, 118:3829-3838.
31. Huang C., et al. Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat. Cell Biol. 2009, 11:624-630.
32. Luo B.H., et al. Locking the β3 integrin I-like domain into high and low affinity conformations with disulfides. J. Biol. Chem. 2004, 279:10215-10221.
33. Partridge A.W., et al. Transmembrane domain helix packing stabilizes integrin αIIbβ3 in the low affinity state. J. Biol. Chem. 2005, 280:7294-7300.
34. Kim M., et al. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 2003, 301:1720-1725.
35. Ulmer T.S. Structural basis of transmembrane domain interactions in integrin signaling. Cell Adhes. Migr. 2010, 4:243-248.
36. Zhu J., et al. The structure of a receptor with two associating transmembrane domains on the cell surface: integrin αIIbβ3. Mol. Cell 2009, 34:234-249.
37. Lau T.L., et al. The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J. 2009, 28:1351-1361.
38. Hughes P.E., et al. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J. Biol. Chem. 1996, 271:6571-6574.
39. Tadokoro S., et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003, 302:103-106.
40. Garcia-Alvarez B., et al. Structural determinants of integrin recognition by talin. Mol. Cell 2003, 11:49-58.
41. Wegener K.L., et al. Structural basis of integrin activation by talin. Cell 2007, 128:171-182.
42. Anthis N.J., et al. The structure of an integrin/talin complex reveals the basis of inside-out signal transduction. EMBO J. 2009, 28:3623-3632.
43. Anthis N.J., et al. Structural diversity in integrin/talin interactions. Structure 2010, 18:1654-1666.
44. Calderwood D.A., et al. The phosphotyrosine binding-like domain of talin activates integrins. J. Biol. Chem. 2002, 277:21749-21758.
45. Bouaouina M., et al. The N-terminal domains of talin cooperate with the phosphotyrosine binding-like domain to activate β1 and β3 integrins. J. Biol. Chem. 2008, 283:6118-6125.
46. Goult B.T., et al. Structure of a double ubiquitin-like domain in the talin head: a role in integrin activation. EMBO J. 2010, 29:1069-1080.
47. Elliott P.R., et al. The structure of the talin head reveals a novel extended conformation of the FERM domain. Structure 2010, 18:1289-1299.
48. Meves A., et al. The kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol. 2009, 19:504-513.
49. Goult B.T., et al. The structure of the N-terminus of kindlin-1: a domain important for αIIbβ3 integrin activation. J. Mol. Biol. 2009, 394:944-956.
50. Moser M., et al. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat. Med. 2008, 14:325-330.
51. Harburger D.S., et al. Kindlin-1 and -2 directly bind the C-terminal region of β integrin cytoplasmic tails and exert integrin-specific activation effects. J. Biol. Chem. 2009, 284:11485-11497.
52. Bhunia A., et al. NMR solution conformations and interactions of integrin αLβ2 cytoplasmic tails. J. Biol. Chem. 2009, 284:3873-3884.
53. Smagghe B.J., et al. Modulation of integrin activation by an entropic spring in the β-knee. J. Biol. Chem. 2010, 285:32954-32966.
54. Kiema T., et al. The molecular basis of filamin binding to integrins and competition with talin. Mol. Cell 2006, 21:337-347.
55. Millon-Fremillon A., et al. Cell adaptive response to extracellular matrix density is controlled by ICAP-1-dependent β1-integrin affinity. J. Cell Biol. 2008, 180:427-441.
56. Oxley C.L., et al. An integrin phosphorylation switch: the effect of β3 integrin tail phosphorylation on Dok1 and talin binding. J. Biol. Chem. 2008, 283:5420-5426.
57. Anthis N.J., et al. β Integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation. J. Biol. Chem. 2009, 284:36700-36710.
58. Bledzka K., et al. Tyrosine phosphorylation of integrin β3 regulates kindlin-2 binding and integrin activation. J. Biol. Chem. 2010, 285:30370-30374.
59. Deshmukh L., et al. Integrin β3 phosphorylation dictates its complex with the Shc phosphotyrosine-binding (PTB) domain. J. Biol. Chem. 2010, 285:34875-34884.
60. Takala H., et al. β2 integrin phosphorylation on Thr758 acts as a molecular switch to regulate 14-3-3 and filamin binding. Blood 2008, 112:1853-1862.
61. Kopp P.M., et al. Studies on the morphology and spreading of human endothelial cells define key inter- and intramolecular interactions for talin1. Eur. J. Cell Biol. 2010, 89:661-673.
62. Patla I., et al. Dissecting the molecular architecture of integrin adhesion sites by cryo-electron tomography. Nat. Cell Biol. 2010, 12:909-915.
63. Etzioni A. Genetic etiologies of leukocyte adhesion defects. Curr. Opin. Immunol. 2009, 21:481-486.
64. Wang S., Basson M.D. Integrin-linked kinase: a multi-functional regulator modulating extracellular pressure-stimulated cancer cell adhesion through focal adhesion kinase and AKT. Cell Oncol. 2009, 31:273-289.
65. Cox D., et al. Integrins as therapeutic targets: lessons and opportunities. Nat. Rev. Drug Discov. 2010, 9:804-820.
66. Auzzas L., et al. Targeting αvβ3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Curr. Med. Chem. 2010, 17:1255-1299.
67. Cantor J.M., et al. Integrin-associated proteins as potential therapeutic targets. Immunol. Rev. 2008, 223:236-251.
68. Xiong J.P., et al. Crystal structure of the extracellular segment of integrin αvβ3. Science 2001, 294:339-345.
69. Arnaout M.A., et al. Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 2007, 19:495-507.
70. Askari J.A., et al. Linking integrin conformation to function. J. Cell Sci. 2009, 122:165-170.
71. Xie C., et al. Structure of an integrin with an alphaI domain, complement receptor type 4. EMBO J. 2010, 29:666-679.
72. Xiong J.P., et al. Crystal structure of the complete integrin αVβ3 ectodomain plus an α/β transmembrane fragment. J. Cell Biol. 2009, 186:589-600.
73. Adair B.D., et al. Three-dimensional EM structure of the ectodomain of integrin αVβ3 in a complex with fibronectin. J. Cell Biol. 2005, 168:1109-1118.
74. Xiao T., et al. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004, 432:59-67.
75. Senetar M.A., et al. Talin2 is induced during striated muscle differentiation and is targeted to stable adhesion complexes in mature muscle. Cell Motil. Cytoskeleton 2007, 64:157-173.
76. Fehon R.G., et al. Organizing the cell cortex: the role of ERM proteins. Nat. Rev. Mol. Cell Biol. 2010, 11:276-287.
77. Calderwood D.A., et al. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2272-2277.
78. Wegener K.L., et al. Structural basis for the interaction between the cytoplasmic domain of the hyaluronate receptor layilin and the talin F3 subdomain. J. Mol. Biol. 2008, 382:112-126.
79. Goksoy E., et al. Structural basis for the autoinhibition of talin in regulating integrin activation. Mol. Cell 2008, 31:124-133.
80. Goult B.T., et al. The structure of an interdomain complex that regulates talin activity. J. Biol. Chem. 2009, 284:15097-15106.
81. Fassler R., Meyer M. Consequences of lack of β1 integrin gene expression in mice. Genes Dev. 1995, 9:1896-1908.
82. Czuchra A., et al. Genetic analysis of β1 integrin " activation motifs" in mice. J. Cell Biol. 2006, 174:889-899.
83. Hodivala-Dilke K.M., et al. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 1999, 103:229-238.
84. Law D.A., et al. Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function. Nature 1999, 401:808-811.
85. Calderwood D.A., et al. Increased filamin binding to β-integrin cytoplasmic domains inhibits cell migration. Nat. Cell Biol. 2001, 3:1060-1068.